{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:58:31Z","timestamp":1790906311555,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s10585-006-9002-5","type":"journal-article","created":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T01:57:12Z","timestamp":1146621432000},"page":"605-614","source":"Crossref","is-referenced-by-count":50,"title":["Rat Models of Bone Metastases"],"prefix":"10.1007","volume":"22","author":[{"given":"St\u00e9phane","family":"Blouin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel F\u00e9lix","family":"Basl\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Chappard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,5,3]]},"reference":[{"issue":"8","key":"9002_CR1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","volume":"2","author":"GR Mundy","year":"2002","unstructured":"Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2(8):584\u2013593","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"9002_CR2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","volume":"27","author":"RE Coleman","year":"2001","unstructured":"Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27(3):165\u2013176","journal-title":"Cancer Treat Rev"},{"issue":"3 Suppl","key":"9002_CR3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/cncr.11148","volume":"97","author":"GD Roodman","year":"2003","unstructured":"Roodman GD (2003) Role of stromal-derived cytokines and growth factors in bone metastasis. Cancer 97(3 Suppl):733\u2013738","journal-title":"Cancer"},{"issue":"3\u20134","key":"9002_CR4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1015599831232","volume":"20","author":"ET Keller","year":"2001","unstructured":"Keller ET, Zhang J, Cooper CR et al (2001) Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer Metastasis Rev 20(3\u20134):333\u2013349","journal-title":"Cancer Metastasis Rev"},{"issue":"8 Suppl","key":"9002_CR5","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F","volume":"80","author":"EC Woodhouse","year":"1997","unstructured":"Woodhouse EC, Chuaqui RF, Liotta LA (1997) General mechanisms of metastasis. Cancer 80(8 Suppl):1529\u20131537","journal-title":"Cancer"},{"key":"9002_CR6","first-page":"18","volume":"19","author":"TA Guise","year":"1998","unstructured":"Guise TA, Mundy GR (1998) Cancer and bone. Endocrine Rev 19:18\u201354","journal-title":"Endocrine Rev"},{"issue":"12 Suppl","key":"9002_CR7","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1002\/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y","volume":"88","author":"TA Guise","year":"2000","unstructured":"Guise TA (2000) Molecular mechanisms of osteolytic bone metastases. Cancer 88(12 Suppl):2892\u20132898","journal-title":"Cancer"},{"issue":"1","key":"9002_CR8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrc1528","volume":"5","author":"CJ Logothetis","year":"2005","unstructured":"Logothetis CJ, Lin SH (2005) Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer 5(1):21\u201328","journal-title":"Nat Rev Cancer"},{"issue":"2A","key":"9002_CR9","first-page":"1067","volume":"25","author":"K Liepe","year":"2005","unstructured":"Liepe K, Geidel H, Haase M et al (2005) New model for the induction of osteoblastic bone metastases in rat. Anticancer Res 25(2A):1067\u20131073","journal-title":"Anticancer Res"},{"issue":"2","key":"9002_CR10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s002560000287","volume":"30","author":"AA Kurth","year":"2001","unstructured":"Kurth AA, Muller R (2001) The effect of an osteolytic tumor on the three-dimensional trabecular bone morphology in an animal model. Skeletal Radiol 30(2):94\u201398","journal-title":"Skeletal Radiol"},{"issue":"2","key":"9002_CR11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/j.semnuclmed.2004.11.005","volume":"35","author":"I Fogelman","year":"2005","unstructured":"Fogelman I, Cook G, Israel O et al (2005) Positron emission tomography and bone metastases. Semin Nucl Med 35(2):135\u2013142","journal-title":"Semin Nucl Med"},{"issue":"10","key":"9002_CR12","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nrc1717","volume":"5","author":"RM Hoffman","year":"2005","unstructured":"Hoffman RM (2005) The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer 5(10):796\u2013806","journal-title":"Nat Rev Cancer"},{"issue":"22","key":"9002_CR13","first-page":"6538","volume":"62","author":"P Fournier","year":"2002","unstructured":"Fournier P, Boissier S, Filleur S et al (2002) Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 62(22):6538\u20136544","journal-title":"Cancer Res"},{"issue":"1","key":"9002_CR14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.yrtph.2004.04.003","volume":"40","author":"H Tennekes","year":"2004","unstructured":"Tennekes H, Gembardt C, Dammann M et al (2004) The stability of historical control data for common neoplasms in laboratory rats: adrenal gland (medulla), mammary gland, liver, endocrine pancreas, and pituitary gland. Regul Toxicol Pharmacol 40(1):18\u201327","journal-title":"Regul Toxicol Pharmacol"},{"issue":"3","key":"9002_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/scbi.1995.0023","volume":"6","author":"MN Gould","year":"1995","unstructured":"Gould MN (1995) Rodent models for the study of etiology, prevention and treatment of breast cancer. Semin Cancer Biol 6(3):147\u2013152","journal-title":"Semin Cancer Biol"},{"issue":"3 Suppl","key":"9002_CR16","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/cncr.11150","volume":"97","author":"TJ Rosol","year":"2003","unstructured":"Rosol TJ, Tannehill-Gregg SH, LeRoy BE et al (2003) Animal models of bone metastasis. Cancer 97(3 Suppl):748\u2013757","journal-title":"Cancer"},{"issue":"2","key":"9002_CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.20904","volume":"115","author":"T Imaoka","year":"2005","unstructured":"Imaoka T, Nishimura M, Teramoto A et al (2005) Cooperative induction of rat mammary cancer by radiation and 1-methyl-1-nitrosourea via the oncogenic pathways involving c-Myc activation and H-ras mutation. Int J Cancer 115(2):187\u2013193","journal-title":"Int J Cancer"},{"issue":"1","key":"9002_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1097-0045(20000401)43:1<71::AID-PROS10>3.0.CO;2-H","volume":"43","author":"M Pollard","year":"2000","unstructured":"Pollard M, Wolter WR, Sun L (2000) Prostate-seminal vesicle cancers induced in noble rats. Prostate 43(1):71\u201374","journal-title":"Prostate"},{"issue":"3","key":"9002_CR19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-3835(89)90079-7","volume":"45","author":"M Pollard","year":"1989","unstructured":"Pollard M, Luckert PH, Snyder DL (1989) The promotional effect of testosterone on induction of prostate-cancer in MNU-sensitized L-W rats. Cancer Lett 45(3):209\u2013212","journal-title":"Cancer Lett"},{"issue":"6","key":"9002_CR20","first-page":"1335","volume":"8","author":"AA Geldof","year":"1988","unstructured":"Geldof AA, Rao BR (1988) Doxorubicin treatment increases metastasis of prostate tumor (R3327-MatLyLu). Anticancer Res 8(6):1335\u20131339","journal-title":"Anticancer Res"},{"issue":"5A","key":"9002_CR21","first-page":"1303","volume":"10","author":"AA Geldof","year":"1990","unstructured":"Geldof AA, Rao BR (1990) Factors in prostate cancer metastasis. Anticancer Res 10(5A):1303\u20131306","journal-title":"Anticancer Res"},{"issue":"4","key":"9002_CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/pros.2990160402","volume":"16","author":"AA Geldof","year":"1990","unstructured":"Geldof AA, Rao BR (1990) Prostatic tumor (R3327) skeletal metastasis. Prostate 16(4):279\u2013290","journal-title":"Prostate"},{"issue":"5","key":"9002_CR23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0090-4295(96)00576-6","volume":"49","author":"AA Geldof","year":"1997","unstructured":"Geldof AA, van den Tillaar PL, Newling DW et al (1997) Radionuclide therapy for prostate cancer lumbar metastasis prolongs symptom-free survival in a rat model. Urology 49(5):795\u2013801","journal-title":"Urology"},{"issue":"4","key":"9002_CR24","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0022-5347(17)36890-8","volume":"148","author":"YC Sun","year":"1992","unstructured":"Sun YC, Geldof AA, Newling DW et al (1992) Progression delay of prostate tumor skeletal metastasis effects by bisphosphonates. J Urol 148(4):1270\u20131273","journal-title":"J Urol"},{"issue":"17","key":"9002_CR25","first-page":"4613","volume":"52","author":"M Haq","year":"1992","unstructured":"Haq M, Goltzman D, Tremblay G et al (1992) Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells. Cancer Res 52(17):4613\u20134619","journal-title":"Cancer Res"},{"issue":"9","key":"9002_CR26","first-page":"2372","volume":"54","author":"A Achbarou","year":"1994","unstructured":"Achbarou A, Kaiser S, Tremblay G et al (1994) Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res 54(9):2372\u20132377","journal-title":"Cancer Res"},{"issue":"2","key":"9002_CR27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<257::AID-IJC15>3.0.CO;2-3","volume":"80","author":"SA Rabbani","year":"1999","unstructured":"Rabbani SA, Gladu J, Harakidas P et al (1999) Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo. Int J Cancer 80(2):257\u2013264","journal-title":"Int J Cancer"},{"issue":"2","key":"9002_CR28","first-page":"199","volume":"6","author":"M Koutsilieris","year":"1992","unstructured":"Koutsilieris M (1992) PA-III rat prostate adenocarcinoma cells (review). In Vivo 6(2):199\u2013203","journal-title":"In Vivo"},{"issue":"1","key":"9002_CR29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/1040-8428(94)00122-A","volume":"18","author":"M Koutsilieris","year":"1995","unstructured":"Koutsilieris M (1995) Skeletal metastases in advanced prostate cancer: cell biology and therapy. Crit Rev Oncol Hematol 18(1):51\u201364","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"9002_CR30","first-page":"481","volume":"13","author":"M Koutsilieris","year":"1993","unstructured":"Koutsilieris M, Frenette G, Lazure C et al (1993) Urokinase-type plasminogen activator: a paracrine factor regulating the bioavailability of IGFs in PA-III cell-induced osteoblastic metastases. Anticancer Res 13(2):481\u2013486","journal-title":"Anticancer Res"},{"issue":"1","key":"9002_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0304-3835(95)04105-2","volume":"101","author":"M Pollard","year":"1996","unstructured":"Pollard M (1996) Thalidomide promotes metastasis of prostate adenocarcinoma cells (PA-III) in L-W rats. Cancer Lett 101(1):21\u201324","journal-title":"Cancer Lett"},{"issue":"4","key":"9002_CR32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/pros.2990190405","volume":"19","author":"C Polychronakos","year":"1991","unstructured":"Polychronakos C, Janthly U, Lehoux JG et al (1991) Mitogenic effects of insulin and insulin-like growth factors on PA-III rat prostate adenocarcinoma cells: characterization of the receptors involved. Prostate 19(4):313\u2013321","journal-title":"Prostate"},{"issue":"4","key":"9002_CR33","first-page":"1334","volume":"51","author":"H Simpkins","year":"1991","unstructured":"Simpkins H, Lehman JM, Mazurkiewicz JE et al (1991) A morphological and phenotypic analysis of Walker 256 cells. Cancer Res 51(4):1334\u20131338","journal-title":"Cancer Res"},{"key":"9002_CR34","first-page":"527","volume":"21","author":"ER Fisher","year":"1961","unstructured":"Fisher ER, Fisher B (1961) Electron microscopic, histologic, and histochemical features of the Walker carcinoma. Cancer Res 21:527\u2013531","journal-title":"Cancer Res"},{"issue":"2","key":"9002_CR35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/jps.10032","volume":"91","author":"D Stepensky","year":"2002","unstructured":"Stepensky D, Golomb G, Hoffman A (2002) Pharmacokinetic and pharmacodynamic evaluation of intermittent versus continuous alendronate administration in rats. J Pharm Sci 91(2):508\u2013516","journal-title":"J Pharm Sci"},{"issue":"4","key":"9002_CR36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/BF02555239","volume":"41","author":"R Rizzoli","year":"1987","unstructured":"Rizzoli R, Fleisch H (1987) The Walker 256\/B carcinosarcoma in thyroparathyroidectomized rats: a model to evaluate\u2423inhibitors of bone resorption. Calcif Tissue Int 41(4):202\u2013207","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"9002_CR37","first-page":"3007","volume":"44","author":"A Jung","year":"1984","unstructured":"Jung A, Bornand J, Mermillod B et al (1984) Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat. Cancer Res 44(7):3007\u20133011","journal-title":"Cancer Res"},{"issue":"5","key":"9002_CR38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S8756-3282(00)00259-3","volume":"26","author":"M Juraschek","year":"2000","unstructured":"Juraschek M, Seibel MJ, Woitge HW et al (2000) Association between histomorphometry and biochemical markers of bone turnover in a longitudinal rat model of parathyroid hormone-related peptide (PTHrP)-mediated tumor osteolysis. Bone 26(5):475\u2013483","journal-title":"Bone"},{"issue":"22","key":"9002_CR39","first-page":"5452","volume":"53","author":"PJ Kostenuik","year":"1993","unstructured":"Kostenuik PJ, Orr FW, Suyama K et al (1993) Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats. Cancer Res 53(22):5452\u20135457","journal-title":"Cancer Res"},{"issue":"6","key":"9002_CR40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF00133470","volume":"10","author":"PJ Kostenuik","year":"1992","unstructured":"Kostenuik PJ, Singh G, Suyama KL et al (1992) Stimulation of bone resorption results in a selective increase in the growth rate of spontaneously metastatic Walker 256 cancer cells in bone. Clin Exp Metastasis 10(6):411\u2013418","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"9002_CR41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF00133469","volume":"10","author":"PJ Kostenuik","year":"1992","unstructured":"Kostenuik PJ, Singh G, Suyama KL et al (1992) A quantitative model for spontaneous bone metastasis: evidence for a mitogenic effect of bone on Walker 256 cancer cells. Clin Exp Metastasis 10(6):403\u2013410","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"9002_CR42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/1097-0142(19930701)72:1<91::AID-CNCR2820720118>3.0.CO;2-2","volume":"72","author":"B Krempien","year":"1993","unstructured":"Krempien B, Manegold C (1993) Prophylactic treatment of skeletal metastases, tumor-induced osteolysis, and hypercalcemia in rats with the bisphosphonate Cl2MBP. Cancer 72(1):91\u201398","journal-title":"Cancer"},{"issue":"1","key":"9002_CR43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000226528","volume":"45","author":"B Krempien","year":"1988","unstructured":"Krempien B, Wingen F, Eichmann T et al (1988) Protective effects of a prophylactic treatment with the bisphosphonate 3-amino-1-hydroxypropane-1,1-bisphosphonic acid on the development of tumor osteopathies in the rat: experimental studies with the Walker carcinosarcoma 256. Oncology 45(1):41\u201346","journal-title":"Oncology"},{"issue":"6","key":"9002_CR44","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/cncr.11646","volume":"98","author":"R Krempien","year":"2003","unstructured":"Krempien R, Huber PE, Harms W et al (2003) Combination of early bisphosphonate administration and irradiation leads to improved remineralization and restabilization of osteolytic bone metastases in an animal tumor model. Cancer 98(6):1318\u20131324","journal-title":"Cancer"},{"issue":"4","key":"9002_CR45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/bjc.1973.154","volume":"28","author":"TJ Powles","year":"1973","unstructured":"Powles TJ, Clark SA, Easty DM et al (1973) The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer. Br J Cancer 28(4):316\u2013321","journal-title":"Br J Cancer"},{"issue":"10","key":"9002_CR46","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0024-3205(95)00005-Q","volume":"56","author":"JM Wan","year":"1995","unstructured":"Wan JM, Istfan NW, Ye SL et al (1995) Insulin-like growth factor-1 is not mitogenic for the Walker-256 carcinosarcoma. Life Sci 56(10):747\u2013756","journal-title":"Life Sci"},{"issue":"1","key":"9002_CR47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF00402773","volume":"111","author":"F Wingen","year":"1986","unstructured":"Wingen F, Eichmann T, Manegold C et al (1986) Effects of new bisphosphonic acids on tumor-induced bone destruction in the rat. J Cancer Res Clin Oncol 111(1):35\u201341","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"9002_CR48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1055\/s-2007-979988","volume":"27","author":"ME Cohen-Solal","year":"1995","unstructured":"Cohen-Solal ME, Bouizar Z, Denne MA et al (1995) 1,25 dihydroxyvitamin D and dexamethasone decrease in vivo Walker carcinoma growth, but not parathyroid hormone related protein secretion. Horm Metab Res 27(9):403\u2013407","journal-title":"Horm Metab Res"},{"issue":"2","key":"9002_CR49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3835(98)00245-6","volume":"134","author":"MJ Municio Campo del","year":"1998","unstructured":"Municio del Campo MJ, Villameytide ML (1998) Regulation by calcium of the synthesis of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in Walker 256 carcinosarcoma cells: comparison with synthesis regulation from renal phenotype cells (LLC-PK1). Cancer Lett 134(2):147\u2013153","journal-title":"Cancer Lett"},{"issue":"4","key":"9002_CR50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/8756-3282(96)00002-6","volume":"18","author":"T Schilling","year":"1996","unstructured":"Schilling T, Pecherstorfer M, Blind E et al (1996) Glucocorticoids decrease the production of parathyroid hormone- related protein in vitro but not in vivo in the Walker carcinosarcoma 256 rat model. Bone 18(4):315\u2013319","journal-title":"Bone"},{"issue":"1","key":"9002_CR51","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S8756-3282(01)00644-5","volume":"30","author":"AA Kurth","year":"2002","unstructured":"Kurth AA, Kim SZ, Sedlmeyer I et al (2002) Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the rat. Bone 30(1):300\u2013306","journal-title":"Bone"},{"issue":"2","key":"9002_CR52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0736-0266(00)90014-7","volume":"19","author":"AH Kurth","year":"2001","unstructured":"Kurth AH, Wang C, Hayes WC et al (2001) The evaluation of a rat model for the analysis of densitometric and biomechanical properties of tumor-induced osteolysis. J Orthop Res 19(2):200\u2013205","journal-title":"J Orthop Res"},{"issue":"15","key":"9002_CR53","first-page":"5705","volume":"9","author":"E Alvarez","year":"2003","unstructured":"Alvarez E, Westmore M, Galvin RJ et al (2003) Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption. Clin Cancer Res 9(15):5705\u20135713","journal-title":"Clin Cancer Res"},{"issue":"7","key":"9002_CR54","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/01.rli.0000167124.89782.db","volume":"40","author":"P Marzola","year":"2005","unstructured":"Marzola P, Ramponi S, Nicolato E et al (2005) Effect of tamoxifen in an experimental model of breast tumor studied by dynamic contrast-enhanced magnetic resonance imaging and different contrast agents. Invest Radiol 40(7):421\u2013429","journal-title":"Invest Radiol"},{"issue":"4","key":"9002_CR55","first-page":"1004","volume":"54","author":"RT Stanko","year":"1994","unstructured":"Stanko RT, Mullick P, Clarke MR et al (1994) Pyruvate inhibits growth of mammary adenocarcinoma 13762 in rats. Cancer Res 54(4):1004\u20131007","journal-title":"Cancer Res"},{"issue":"6","key":"9002_CR56","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/ijc.20178","volume":"110","author":"M Imai","year":"2004","unstructured":"Imai M, Ohta R, Okada N et al (2004) Inhibition of a complement regulator in vivo enhances antibody therapy in a model of mammary adenocarcinoma. Int J Cancer 110(6):875\u2013881","journal-title":"Int J Cancer"},{"issue":"1","key":"9002_CR57","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1124\/jpet.103.057893","volume":"309","author":"JE Onyia","year":"2004","unstructured":"Onyia JE, Galvin RJ, Ma YL et al (2004) Novel and selective small molecule stimulators of osteoprotegerin expression inhibit bone resorption. J Pharmacol Exp Ther 309(1):369\u2013379","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"9002_CR58","first-page":"507","volume":"68","author":"A Neri","year":"1982","unstructured":"Neri A, Welch D, Kawaguchi T et al (1982) Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst 68(3):507\u2013517","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"9002_CR59","first-page":"65","volume":"3","author":"DR Welch","year":"1983","unstructured":"Welch DR, Neri A, Nicolson GL (1983) Comparison of \u2018spontaneous\u2019 and \u2018experimental\u2019 metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones. Invas Metastasis 3(2):65\u201380","journal-title":"Invas Metastasis"},{"issue":"3","key":"9002_CR60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0960-7404(96)80014-4","volume":"5","author":"H Tamura","year":"1996","unstructured":"Tamura H, Ishii S, Ikeda T et al (1996) Therapeutic efficacy of pamidronate in combination with chemotherapy to bone metastasis of breast cancer in a rat model. Surg Oncol 5(3):141\u2013147","journal-title":"Surg Oncol"},{"issue":"1","key":"9002_CR61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02966902","volume":"6","author":"H Tamura","year":"1999","unstructured":"Tamura H, Ishii S, Ikeda T et al (1999) The relationship between urinary pyridinoline, deoxypyridinoline and bone metastasis in a rat breast cancer model. Breast Cancer 6(1):23\u201328","journal-title":"Breast Cancer"},{"issue":"3","key":"9002_CR62","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF02984550","volume":"11","author":"N Wada","year":"2004","unstructured":"Wada N, Ishii S, Ikeda T et al (2004) Inhibition of bone metastasis from breast cancer with pamidronate resulting in reduction of urinary pyridinoline and deoxypyridinoline in a rat model. Breast Cancer 11(3):282\u2013287","journal-title":"Breast Cancer"},{"issue":"11","key":"9002_CR63","first-page":"3120","volume":"62","author":"G Henriksen","year":"2002","unstructured":"Henriksen G, Breistol K, Bruland OS et al (2002) Significant antitumor effect from bone-seeking, alpha-particle-emitting (223)Ra demonstrated in an experimental skeletal metastases model. Cancer Res 62(11):3120\u20133125","journal-title":"Cancer Res"},{"issue":"3","key":"9002_CR64","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ijc.11397","volume":"107","author":"M Neudert","year":"2003","unstructured":"Neudert M, Fischer C, Krempien B et al (2003) Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumour growth. Int J Cancer 107(3):468\u2013477","journal-title":"Int J Cancer"},{"issue":"2","key":"9002_CR65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ijc.20840","volume":"115","author":"T Bauerle","year":"2005","unstructured":"Bauerle T, Adwan H, Kiessling F et al (2005) Characterization of a rat model with site-specific bone metastasis nduced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein. Int J Cancer 115(2):177\u2013186","journal-title":"Int J Cancer"},{"issue":"1\u20132","key":"9002_CR66","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3959(01)00437-7","volume":"96","author":"SJ Medhurst","year":"2002","unstructured":"Medhurst SJ, Walker K, Bowes M et al (2002) A rat model of bone cancer pain. Pain 96(1\u20132):129\u2013140","journal-title":"Pain"},{"issue":"19","key":"9002_CR67","doi-asserted-by":"crossref","first-page":"PL275","DOI":"10.1016\/S0024-3205(97)00839-4","volume":"61","author":"PO Ekstrom","year":"1997","unstructured":"Ekstrom PO, Giercksky KE, Andersen A et al (1997) Intratumoral differences in methotrexate levels within human osteosarcoma xenografts studied by microdialysis. Life Sci 61(19):PL275\u2013PL280","journal-title":"Life Sci"},{"issue":"2","key":"9002_CR68","first-page":"148","volume":"3","author":"C Andersen","year":"2003","unstructured":"Andersen C, Bagi CM, Adams SW (2003) Intra-tibial injection of human prostate cancer cell line CWR22 elicits osteoblastic response in immunodeficient rats. J Musculoskelet Neuronal Interact 3(2):148\u2013155","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"9002_CR69","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/bcr275","volume":"3","author":"JS Lawson","year":"2001","unstructured":"Lawson JS, Tran D, Rawlinson WD (2001) From Bittner to Barr: a viral, diet and hormone breast cancer aetiology hypothesis. Breast Cancer Res 3:81\u201385","journal-title":"Breast Cancer Res"},{"key":"9002_CR70","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/B:BREA.0000014044.02728.ac","volume":"83","author":"A Efeyan","year":"2004","unstructured":"Efeyan A, Fabris V, Merani S et al (2004) Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor. Breast Cancer Res Treat 83:233\u2013244","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"9002_CR71","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/ctrv.1999.0133","volume":"25","author":"T Yoneda","year":"1999","unstructured":"Yoneda T, Michigami T, Yi B et al (1999) Use of bisphosphonates for the treatment of bone metastasis in experimental animal models. Cancer Treat Rev 25(5):293\u2013299","journal-title":"Cancer Treat Rev"},{"key":"9002_CR72","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-3057(99)00037-3","volume":"36","author":"O Garc\u00eda","year":"2000","unstructured":"Garc\u00eda O, Blanco MD, Mart\u00edn JA et al (2000) 5-Fluorouracil trapping in poly(2-hydroxyethyl methacrylate-co-acrylamide) hydrogels: in vitro drug delivery studies. Eur Polym J 36:111\u2013122","journal-title":"Eur Polym J"},{"key":"9002_CR73","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1302\/0301-620X.78B1.0780014","volume":"78","author":"HM Wang","year":"1996","unstructured":"Wang HM, Crank S, Oliver G et al (1996) The effect of methotrexate-loaded bone cement on local destruction by the VX2 tumour. J Bone Joint Surg Br 78:14\u201317","journal-title":"J Bone Joint Surg Br"},{"key":"9002_CR74","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s007760100015","volume":"6","author":"SE Utvag","year":"2001","unstructured":"Utvag SE, Korsnes L, Rindal DB et al (2001) Influence of flexible nailing in the later phase of fracture healing: strength and mineralization in rat femora. J Orthop Sci 6:576\u2013584","journal-title":"J Orthop Sci"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-006-9002-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-006-9002-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-006-9002-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T14:32:49Z","timestamp":1559226769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-006-9002-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["9002"],"URL":"https:\/\/doi.org\/10.1007\/s10585-006-9002-5","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}